Technology

GPCR Platform

 

GPCR Platform

The G-Protein Coupled Receptor (GPCR) signaling field has garnered worldwide attention from drug developers since a Nobel prize in Chemistry was awarded in 2012 for research in this area.

Large pharmaceutical companies such as Novartis, Pfizer, Astra Zeneca etc. are heavily investing in modulation of GPCR signaling.

About 30% of marketed drugs target GPCRs.